Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Abstract
Euglycemic hyperinsulinemia evokes both sympathetic activation and vasodilation in skeletal muscle, but the mechanism remains unknown. To determine whether insulin per se or insulin-induced stimulation of carbohydrate metabolism is the main excitatory stimulus, we performed, in six healthy lean subjects, simultaneous microneurographic recordings of muscle sympathetic nerve activity, plethysmographic measurements of calf blood flow, and calorimetric determinations of carbohydrate oxidation rate. Measurements were made during 2 h of: (a) insulin/glucose infusion (hyperinsulinemic [6 pmol/kg per min] euglycemic clamp), (b) exogenous glucose infusion at a rate matched to that attained during protocol a, and (c) exogenous fructose infusion at the same rate as for glucose infusion in protocol b. For a comparable rise in carbohydrate oxidation, insulin/glucose infusion that resulted in twofold greater increases in plasma insulin concentrations than did glucose infusion alone, evoked twofold greater increases in both muscle sympathetic nerve activity and calf blood flow. Fructose infusion, which increased carbohydrate oxidation comparably, but had only a minor effect on insulinemia, did not stimulate either muscle sympathetic nerve activity or calf blood flow. These observations suggest that in humans hyperinsulinemia per se, rather than insulin-induced stimulation of carbohydrate metabolism, is the main mechanism that triggers both sympathetic activation and vasodilation in skeletal muscle.
Overview
CoChat Summary
TL;DR
In healthy lean humans, euglycemic hyperinsulinemia increased muscle sympathetic nerve activity (MSNA) and calf blood flow more than glucose infusion alone despite comparable carbohydrate oxidation, while fructose infusion increased carbohydrate oxidation without stimulating MSNA or calf blood flow. The authors conclude that hyperinsulinemia per se, rather than insulin-induced carbohydrate metabolism, is the main trigger for sympathetic activation and skeletal-muscle vasodilation.
Key findings
- During 2-h insulin/glucose infusion, plasma insulin rose to 376.2±30.0 pmol/liter and increased MSNA burst frequency by 93±18%, calf blood flow by 47±14%, and decreased calf vascular resistance by 19±4%.
- Glucose infusion alone produced comparable carbohydrate oxidation but a smaller insulin rise (282.6±19.8 pmol/liter) and about half the responses: MSNA burst frequency increased 54±10% and calf blood flow 20±6%.
- Fructose infusion increased carbohydrate oxidation even more than insulin/glucose or glucose infusion (23±2 vs 21±1 and 20±1 μmol/kg per min at 90–120 min) but caused only a minor insulin rise (37.2±1.9 to 57.0±2.7 pmol/liter) and had no effect on MSNA, calf blood flow, or calf vascular resistance.
- MSNA and calf blood flow rose significantly at 45 min during insulin/glucose infusion but only at 90 min during glucose infusion; during fructose infusion, glucose oxidation increased by 22±7%.
Methods
- Six lean, healthy subjects (weight 70.8±4.3 kg, BMI 21.8±0.8 kg/m², age 28±4 yr) underwent 2-h protocols: hyperinsulinemic euglycemic clamp (insulin 6 pmol/kg per min), exogenous glucose infusion matched to the clamp, and fructose infusion matched to glucose; five of six subjects completed fructose infusion.
- Simultaneous measurements included microneurographic MSNA recordings from the peroneal nerve, venous occlusion plethysmography for calf blood flow, indirect calorimetry for carbohydrate oxidation, and plasma hormone/substrate assays.
- A fourth protocol in six lean healthy male subjects (age 30±4 yr, BMI 22.9±0.6 kg/m²) used [U-¹³C]glucose infusion and breath ¹³CO₂/plasma [¹³C]glucose enrichment to measure glucose oxidation during fructose infusion.
- Statistical analysis used repeated-measures ANOVA, paired t tests with Bonferroni adjustment, and least-squares correlations; P<0.05 was significant.
Limitations
- The paper states that indirect calorimetry cannot differentiate glucose from fructose oxidation, that nonoxidative glucose disposal calculations were not performed during fructose infusion because endogenous glucose production was not measured and is not suppressed, and that total carbohydrate uptake may have been slightly higher during fructose infusion.
- The paper states that the experiments do not elucidate the underlying mechanisms of insulin-induced sympathetic activation and vasodilation, and that MSNA recordings were targeted specifically at skeletal muscle, so fructose-induced sympathetic outflow to other tissues such as liver cannot be excluded.
- Evident from the text: the main protocols included only six lean healthy subjects (five for fructose), limiting generalizability; the fourth protocol included only male subjects, and the study did not measure interstitial insulin directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 16 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, there is increasing evidence that stimulation of blood flow to insulin-sensitive tissues during insulin/glucose and glucose infusion may be an important determinant of the rate of in vivo glucose uptake (10, 11, 38).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says increased blood flow is closely linked to glucose uptake and may contribute particularly after two hours of hyperinsulinemia. The Protocol describes insulin infusion with glucose clamped at euglycemia, but the paper does not establish the same point for glucose infusion without insulin. Its findings also concern skeletal muscle rather than insulin-sensitive tissues generally. (LLM, conf=0.85)
- Not matchedcites [38] 38. Edelman, S. V., M. Laakso, P. Wallace, G. Brechtel, J. M. Olefsky, and A. D. Baron. 1990. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes. 39:955–964.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“as recent evidence indicates that insulin resistance is associated with attenuated hyperinsulinemia-induced vasodilation in skeletal muscle (10, 11).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. source
The Discussion reports that insulin’s effect on skeletal-muscle blood flow is impaired in obese men and that this defect could be associated with in vivo insulin resistance. Its summary also describes a right-shifted blood-flow response to insulin in obese versus lean subjects. The finding is established for the men studied; extension to other insulin-resistant states is presented as a possibility. (LLM, conf=0.91)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the conclusions of one study were based upon the absence of a detectable effect of glucose infusion on plasma norepinephrine levels (5, 26), a relatively insensitive index of sympathetic discharge (34–36).”
What the sources say
- Partly supportedcites [5] 5. Berne, C., J. Fagius, and F. Niklasson. 1989. Sympathetic response to oral carbohydrate administration. J. Clin. Invest. 84:1403-1409. sourceExperimental — accuracy not yet measured
The Sympathetic activity results report minor or no plasma norepinephrine change after intravenous glucose. But the Discussion bases its conclusion that intravenous glucose did not increase sympathetic activity on direct microelectrode recordings of muscle sympathetic activity, using the norepinephrine results as corroboration—not as the sole basis for the conclusion. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Second, a balance between insulin's opposing sympathoexcitatory pressor and vasodilatory depressor effects may offer a potential explanation for the present, and earlier (6, 7, 26) observations, that in lean healthy subjects acute hyperinsulinemia at high physiologic concentrations does not raise arterial pressure.”
What the sources say
- Partly supportedcites [6] 6. Anderson, E. A., R. P. Hoffman, T. W. Balon, C. A. Sinkey, and A. L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246–2252. sourceExperimental — accuracy not yet measured
The Discussion says that sympathetic pressor and vasodilatory depressor actions appear relatively balanced during acute insulin increases in the physiologic postprandial range, so arterial pressure does not rise. The Subjects section describes healthy males, but their BMI ranged from 21 to 32; the paper does not establish the finding specifically for lean subjects. (LLM, conf=0.82)
- Supportedcites [7] 7. Berne, C., J. Fagius, T. Pollare, and P. Hjemdahl. 1992. The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873–879. source
In the Discussion (page not available in our copy), the authors report that insulin increased muscle sympathetic activity at a high physiological concentration and suggest that this response helps maintain blood pressure despite insulin’s vasodilatory effects. The Abstract reports that blood pressure was not notably affected in the healthy subjects studied. This supports the proposed balance as a possible explanation, rather than an established mechanism. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During fructose infusion, plasma glucose concentrations remained stable, whereas plasma fructose concentrations rose from undetectable levels to 2.0±0.2 mmol/liter by the end of the first hour of infusion, and remained unchanged thereafter (Table I).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 78 claims and to verify the 5 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In our laboratory, the intraobserver and interobserver coefficients of variation of the mean in identifying bursts are < 6% and < 9%, respectively (14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, MS components such as visceral obesity, peripheral insulin resistance, and reactive hyperinsulinemia have been found to result in sympathetic hyperactivity.[5][6][7]”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lean subjects, sympathetic activation evoked by acute elevation of plasma insulin to high physiological concentrations does not raise blood pressure (12–14)”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“In lean healthy subjects, insulin-induced stimulation of muscle blood flow consistently is accompanied by a marked stimulation of sympathetic neural outflow to the same vascular bed (12-14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
In the citing paper
“Sympathetic activation has already been associated with many of the individual components of the MS, such as visceral obesity, 5 insulinemia, 6 EHT, [1][2][3][4] and type 2 diabetes.7”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Nonoxidative glucose disposal (pmol/kg per min) | - | 21±4 | 22±8 | - | 6±1t”
Reported 6 · recomputed 12
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 3
“had no effect on MSNA, calf blood flow, or calf vascular resistance”
§ Analytical methods · p. 3
“| Calf vascular resistance (Units) | 43.3±1.3 | 34.3±1.6* | 32.8±2.0* | 45.6±2.2 | 42.9±2.7* | 40.5±3.2* | 49.7±5.3 | 49.0±5.7t | 45.7±5.2* |”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
Vallbo, A. B., Hagbarth, K. E., Torebjork, H. E., & Wallin, B. G. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.4.919 · Cited by 1,507
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,340
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Hawk’s Physiological Chemistry
Prosky, L. (1966) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/49.2.477 · Cited by 1,047
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Parati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
Hawk's physiological chemistry
HAWK, P. B., & Oser, B. L. (1965) · Medical Entomology and Zoology · Cited by 871
Cited by
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256
Self-citationSteinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N., & Baron, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,223
“In a recent report, Vollenweider and co-workers (8) attempted to separate the role of hyperinsulinemia per se and hyperinsulinemia-induced carbohydrate metabolism in the regulation of skeletal muscle blood flow.”
BackgroundSeravalle, G., & Grassi, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.013 · Cited by 909
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Nitric oxide release accounts for insulin's vascular effects in humans.
Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L., & Nicod, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117621 · Cited by 756
“a variable infusion of 20% dextrose (5).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 147-154
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC293552
- OpenAlex
- W2126021651
- Cited by
- 321
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 15
- FWCI
- 47.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (28668)
- Nestec
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- hyperinsulinemia, euglycemic clamp, muscle sympathetic nerve activity, skeletal muscle blood flow, carbohydrate metabolism, fructose infusion, glucose infusion, insulin, vasodilation, carbohydrate oxidation, energy expenditure
- MeSH terms
- Adult, Blood Glucose, Calorimetry, Catecholamines, Energy Metabolism, Fructose, Humans, Insulin, Muscles, Potassium, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. https://app.cochat.ai/papers/10.1172/jci116542
- The paper
- Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993). Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci116542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.